Special Authority approval data for enoxaparin sodium

OIA response

9 July 2020


Dear [name and contact details withheld]


Thank you for your request dated 11 June 2020 under the Official Information Act 1982 (OIA) for information relating to Special Authority approval data for enoxaparin sodium.  You asked for:

“…the SA approval data broken down by SA criteria for initiations and renewals for Enoxaparin by month for the 2018 and 2019 calendar years. [Is it] possible to get it monthly for the first 5 months (Jan-May 2020) of this year.”

Please find attached the data you have requested. Note that instances where there were low numbers of patients (<10) to receive approval for enoxaparin sodium in any given month have been indicated as such, to ensure that these patients could not be identified.

We trust that this information answers your queries. We are making our information more freely available, so we will now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.

Yours sincerely


Rachel Read

Manager, Policy and Government Services

Download the Special Authority data provided with this OIA response